JPMORGAN MULTI-ASSET GROWTH & INCOME PLC (the 'Company') |
|
Legal Entity Identifier: 549300C0UCY8X2QXW762 |
|
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 31 May 2022 |
|
US 10YR (New Style) Bond Commodity (Future) |
23.7% |
JPMorgan Global High Yield Bond Fund |
9.3% |
Infrastructure Investments Fund |
9.0% |
MSCI EMGMKT (New Style) Index Equity (Future) |
2.7% |
Johnson & Johnson |
2.6% |
JPM China A |
2.5% |
UNITED KINGDOM 0.625% 06/25 |
2.1% |
JPM Global Bond Opportunities |
2.0% |
AbbVie |
1.8% |
3i Group |
1.7% |
Total |
57.4% |
Excludes Investments in Liquidity stocks |
|
Name of contact and telephone number for queries: |
|
Paul Ainger 0044 207 742 6524 |
|
Name of authorised company official responsible for making this notification: |
|
Paul Winship 0044 207 742 9815 - Company Secretary |
|
Date: 17 June 2022 |
|
|
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.